Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 93
Int. j. morphol ; 41(5): 1427-1438, oct. 2023.
Article in English | LILACS | ID: biblio-1521021


SUMMARY: The main cause of mortality and disability globally is myocardial infarction (MI). Isoproterenol (ISO), a β-adrenoceptor agonist, has been used to induce rat myocardial necrosis. Whereas interleukin-37 (IL-37) has anti-inflammatory and cytoprotective properties. The study aimed to investigate the potential protective effects of IL-37 administration on cardiac architecture, oxidative stress, and inflammatory markers during ISO-induced MI in rats. Three groups of adult male rats were used in this study, the normal control group (n=8), ISO-induced MI group (n=8) that received isoproterenol hydrochloride (ISO) (100 mg/kg/day, SC, for the first 2 consecutive days), and IL-37-treated group (ISO+IL-37) (n=8) that received recombinant human IL-37 (40 µg/kg /day, intraperitoneally, for 2 weeks during and after ISO injections. Heart rate (HR.) and ECG changes were monitored. Some oxidative stress markers such as superoxide dismutase (SOD), nitric oxide (NOx), malondialdehyde (MDA), and glutathione (GSH) tissue levels in the tissue homogenate were assayed. Interleukin- 6 (IL-6), tumor necrosis factor- α (TNF-α), caspase-8, P53, and C- reactive protein (CRP) were among the inflammatory markers examined. In addition, serum levels of creatinine kinase (CK-MB) and lactate dehydrogenase (LDH) were analyzed to evaluate the myocardial injury. For histological analysis, tissues were sectioned, fixed in paraffin, and stained with hematoxylin and eosin (H&E), Masson Trichrome and, immunohistochemical against NF-kB, TNF-α, and Caspase-9. IL-37 improved ECG changes, cardiac enzyme markers, and some inflammatory markers of oxidative stress in ISO-induced MI. It also improved the histopathological and immunohistochemical changes in MI. In conclusion: IL-37 might be a promising therapeutic modality in myocardial infarction.

La principal causa de mortalidad y discapacidad a nivel mundial es el infarto de miocardio (IM). El isoproterenol (ISO), un agonista de los receptores adrenérgicos β, se ha utilizado para inducir necrosis miocárdica en ratas. Mientras que la interleucina-37 (IL-37) tiene propiedades antiinflamatorias y citoprotectoras. El estudio tuvo como objetivo investigar los posibles efectos protectores de la administración de IL-37 en la arquitectura cardíaca, el estrés oxidativo y los marcadores inflamatorios durante el infarto de miocardio inducido por ISO en ratas. En este estudio se utilizaron tres grupos de ratas macho adultas, el grupo control normal (n=8), el grupo con IM inducido por ISO (n=8) que recibió clorhidrato de isoproterenol (ISO) (100 mg/kg/día, SC, durante los primeros 2 días consecutivos) y el grupo tratado con IL-37 (ISO+IL- 37) (n=8) que recibió IL-37 humana recombinante (40 µg/kg/día, por vía intraperitoneal, durante 2 semanas durante y después de las inyecciones de ISO. Se monitorearon la frecuencia cardíaca (FC) y los cambios en el ECG. Se analizaron algunos marcadores de estrés oxidativo como la superóxido dismutasa (SOD), el óxido nítrico (NOx), el malondialdehído (MDA) y los niveles tisulares de glutatión (GSH) en el homogeneizado de tejido. La interleucina-6 (IL-6), el factor de necrosis tumoral-α (TNF-α), la caspasa-8, la P53 y la proteína C reactiva (CRP) se encontraban entre los marcadores inflamatorios examinados. Se analizaron los niveles de creatinoquinasa (CK-MB) y lactato deshidrogenasa (LDH) para evaluar la lesión miocárdica; para el análisis histológico se seccionaron los tejidos, se fijaron en parafina y se tiñeron con hematoxilina y eosina (H&E), Tricromo de Masson e inmunohistoquímica contra NF-kB, TNF-α y Caspasa-9. IL-37 mejoró los cambios de ECG, los marcadores de enzimas cardíacas y algunos marcadores inflamatorios de estrés oxidativo en el IM inducido por ISO. Además mejoró los cambios histopatológicos e inmunohistoquímicos en MI. En conclusión: la IL-37 podría ser una modalidad terapéutica prometedora en el infarto de miocardio.

Animals , Male , Rats , Interleukins/administration & dosage , Heart/drug effects , Myocardial Infarction/chemically induced , Myocardial Infarction/prevention & control , Immunohistochemistry , Rats, Wistar , Oxidative Stress/drug effects , Inflammation , Isoproterenol/adverse effects
Braz. J. Pharm. Sci. (Online) ; 59: e21639, 2023. tab, graf
Article in English | LILACS | ID: biblio-1439506


ABSTRACT Herein, we examined the protective effect of metoprolol combined with atractylenolide I (Atr I) in acute myocardial infarction (AMI) by regulating the SIRT3 (silent information regulator 3)/ß-catenin/peroxisome proliferator-activated receptor gamma (PPAR-γ) signaling pathway. Briefly, 50 rats were randomly divided into the sham operation, model, metoprolol, Atr I, and combination metoprolol with Atr I groups (combined treatment group). The AMI model was established by ligating the left anterior descending coronary artery. After treatment, infarct size, histopathological changes, and cell apoptosis were examined using 2,3,5-triphenyltetrazolium chloride staining, hematoxylin-eosin staining, and the TUNEL assay. The left ventricular ejection fraction (LVEF), left ventricular fraction shortening (LVFS), and left ventricular mass index (LVMI) were detected by echocardiography. Endothelin-1 (ET-1), nitric oxide (NO), tumor necrosis factor-alpha (TNF-α), and interleukin-6 (IL-6) levels were detected using enzyme-linked immunosorbent assays. Furthermore, we measured lactate dehydrogenase (LDH), creatine kinase (CK) isoenzyme (CK-MB), and CK levels. Western blotting was performed to determine the expression of SIRT3, ß-catenin, and PPAR-γ. Herein, the combined treatment group exhibited increased levels of LVEF, LVFS, and NO, whereas LVMI, ET-1, TNF-α, IL-6, LDH, CK-MB, and CK levels were decreased. Importantly, the underlying mechanism may afford protection against AMI by increasing the expression levels of SIRT3, ß-catenin, and PPAR-γ

Animals , Male , Female , Rats , Sirtuin 3/pharmacology , Metoprolol/agonists , Myocardial Infarction/chemically induced , Echocardiography/instrumentation , Creatine Kinase/classification , Catenins/adverse effects
Rev. méd. Chile ; 144(1): 39-46, ene. 2016. graf, tab
Article in Spanish | LILACS | ID: lil-776973


Background: Consumption of illicit drugs (ID) has been associated with an increased risk of acute myocardial infarction (AMI). There is limited national evidence about the impact of substance use over the clinical presentation, management and outcomes of AMI patients. Aim: To describe the prevalence of ID consumption in patients within the Chilean Registry of Myocardial Infarction (GEMI), comparing clinical characteristics, management and outcome according to consumption status. Material and Methods: We reviewed data from the GEMI registry between 2001 and 2013, identifying 18,048 patients with AMI. The sample was stratified according to presence or absence of previous ID consumption, comparing different demographic and clinical variables between groups. Results: Two hundred eighty five patients (1.6%) had history of ID consumption (cocaine in 66%, cannabis in 35% and central nervous system stimulants in 24.0%). Compared with non-users, ID consumers were younger, predominantly male and had a lower prevalence of cardiovascular risk factors, except for tobacco smoking (86.3% and 42.5% respectively, p < 0.01). Among consumers, there was a higher percentage of ST segment elevation (85.2% and 67.8% respectively, p < 0.01) and anterior wall AMI (59.9 and 49.5% respectively, p = 0.01). Additionally, they had a higher rate of primary angioplasty (48.8% and 25.5% respectively, p < 0.01). There was no difference in hospital mortality between groups when stratified by age. Conclusions: A low percentage of patients with AMI had a previous history of ID consumption in our national setting. These patients were younger and had a greater frequency of ST segment elevation AMI, which probably determined a more invasive management.

Humans , Male , Female , Adult , Middle Aged , Illicit Drugs/adverse effects , Myocardial Infarction/chemically induced , Cannabis/adverse effects , Chile/epidemiology , Prevalence , Cross-Sectional Studies , Risk Factors , Cocaine/adverse effects , Myocardial Infarction/mortality
Braz. j. infect. dis ; 17(6): 691-700, Nov.-Dec. 2013. tab
Article in English | LILACS | ID: lil-696971


INTRODUCTION: In recent years, there has been growing concern about an increasing rate of cardiovascular diseases in human immunodeficiency virus-infected patients, which could be associated with side effects of highly active antiretroviral therapy. It is likely that the metabolic disorders related to anti-human immunodeficiency virus treatment will eventually translate into a increased cardiovascular risk in patients submitted to such regimens. OBJECTIVE: To evaluate if human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy are at higher risk of cardiovascular diseases than human immunodeficiency virus infected patients not receiving highly active antiretroviral therapy, or the general population. RESEARCH DESIGN AND METHODS: We conducted a computer-based search in representative databases, and also performed manual tracking of citations in selected articles. RESULT: The available evidence suggests an excess risk of cardiovascular events in human immunodeficiency virus-infected persons compared to non-human immunodeficiency virus infected individuals. The use of highly active antiretroviral therapy is associated with increased levels of total cholesterol, triglycerides, low-density lipoprotein and morphological signs of cardiovascular diseases. Some evidence suggested that human immunodeficiency virus-infected individuals on highly active antiretroviral therapy regimens are at increased risk of dyslipidemia, ischemic heart disease, and myocardial infarction, particularly if the highly active antiretroviral therapy regimen contains a protease inhibitor. CONCLUSION: Physicians must weigh the cardiovascular risk against potential benefits when prescribing highly active antiretroviral therapy. Careful cardiac screening is warranted for patients who are being evaluated for, or who are receiving highly active antiretroviral therapy regimens, particularly for those with known underlying cardiovascular risk factors. A better understanding of the molecular mechanisms responsible for increased risk of cardiovascular diseases in human immunodeficiency virus-infected patients will lead to the discovery of new drugs that will reduce cardiovascular risk in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy.

Humans , Anti-HIV Agents/adverse effects , Antiretroviral Therapy, Highly Active/adverse effects , Cardiovascular Diseases/chemically induced , Anti-HIV Agents/administration & dosage , Dyslipidemias/chemically induced , Myocardial Infarction/chemically induced , Myocardial Ischemia/chemically induced , Risk Factors
Indian J Exp Biol ; 2013 Aug; 51(8): 653-660
Article in English | IMSEAR | ID: sea-149368


Isoproterenol injection (100 mg/kg; sc) produced changes in ECG pattern including ST-segment elevation and suppressed R-amplitude. The methanolic extract of M. vulgare at doses of 10, 20, and 40 mg/kg significantly amended the ECG changes. A severe myocardial necrosis and edematous along with a sharp reduction in the arterial blood pressure, left ventricular contractility (LVdP/dtmax or min), but a marked increase in the left ventricular end-diastolic pressure (LVEDP) were seen in the isoproterenol group. All parameters were significantly improved by the extract treatment. The extract (10 mg/kg) strongly increased LVdP/dtmax. Similarly, treatment with 40 mg/kg of M. vulgare lowered the elevated LVEDP and the heart to body weight ratio. In addition to in vitro antioxidant activity, the extract suppressed markedly the elevation of malondialdehyde levels both in serum and in myocardium. The results demonstrate that M. vulgare protects myocardium against isoproterenol-induced acute myocardial infarction and suggest that the effects could be related to antioxidant activities.

Animals , Antioxidants/pharmacology , Cardiotonic Agents/pharmacology , Electrocardiography , Heart/drug effects , Heart/physiopathology , Isoproterenol/toxicity , Lipid Peroxidation/drug effects , Male , Malondialdehyde/metabolism , Marrubium/chemistry , Methanol/chemistry , Myocardial Infarction/chemically induced , Myocardial Infarction/drug therapy , Myocardial Infarction/pathology , Oxidative Stress/drug effects , Rats , Rats, Wistar
Botucatu; s.n; 2013. 64 p. graf, tab.
Thesis in Portuguese | LILACS | ID: lil-751121


Um dos mecanismos que explica como o infarto agudo do miocárdio (IAM) evolui para insuficiência cardíaca é denominado de remodelação ventricular. Dentre as inúmeras alterações bioquímicas associadas ao processo destaca-se o estresse oxidativo. O consumo habitual do chá verde (CV) é associado a benefícios à saúde, devido às suas propriedades, antioxidante, antiiflamatória, antiapoptótica, antiproliferativa, antimutagênica. Estas são atribuídas às catequinas, seu composto bioativo. Portanto, é possível que o extrato de chá verde atenue alguns parâmetros envolvidos na remodelação cardíaca. O objetivo do trabalho foi avaliar se o extrato de chá verde atenua a remodelação cardíaca após o infarto agudo do miocárdio. Para tanto foram utilizados ratos Wistar machos divididos em quatro grupos: controle padrão (CP) (28-sham); extrato do CV (CV) (32-sham e extrato de chá verde); infarto padrão (IP) (25-animais infartados controles); infarto e extrato do CV (ICV) (26- animais infartados e extrato do CV). Ecocardiografia inicial foi realizada após cinco dias ao IAM. A partir de uma divisão homogênea dos animais, considerando o tamanho do infarto maior a 35%, iniciou-se o tratamento. Ao final de três meses estes animais foram estudados por meio de ecocardiografia, morfometria, dosagens bioquímicas de enzimas do estresse oxidativo, metabolismo energético, perfil lipídico sérico, inibidor tecidual de metaloprotease (TIMP-1) e zimografia para atividade das metaloproteases (MMP-2 e MMP-9). Nos resultados, observou-se aumento do diâmetro diastólico do ventrículo esquerdo pelo peso corporal, diâmetro sistólico do ventrículo esquerdo pelo peso corporal e diâmetro do átrio esquerdo pelo peso corporal nos grupos com IAM, mas houve atenuação nos ICV. O tempo de desaceleração da onda E foi reduzido no IP, o que não foi observado no ICV, tendo valor similar ao CV...

One mechanism that explains how acute myocardial infarction develops into heart failure is called ventricular remodeling. Among the many biochemical changes associated with the process stands oxidative stress. The regular consumption of green tea (GT) is associated with health benefits due to its properties such as antioxidant, anti-inflammatory, antiapoptotic, antiproliferative, antimutagenic. These are attributed to catechins, its bioactive compound. Therefore, it is possible that GT extract mitigate some parameters involved in cardiac remodeling. The objective of this study was to assess whether the green tea extract attenuates cardiac remodeling after acute myocardial infarction. For both, male Wistar rats were allocated in 4 groups: control (C-28 sham); green tea extract (GT-32 sham and GT); infarction group (MI-25 infarcted animals controls); infarction and green tea extract (IGT-26 infarcted animals and GT). To start the treatment an initial echocardiography was performed five days after the myocardial infarction, from a homogeneous division of the animals, considering the size of the infarction greater than 35%. At the end of three months these animals were studied by echocardiography, morphometry, biochemical enzyme of the oxidative stress, energy metabolism, lipid profile, tissue inhibitor of metalloproteinase (TIMP-1) and zymography for activity of metalloproteinases (MMP-2 and MMP-9). The results showed an increase in left ventricular diastolic diameter by body weight, left ventricular systolic diameter by body weight and left atrial diameter by body weight in groups with MI, but there was attenuation in IGT. The deceleration time of the E wave was reduced in MI, which was not observed in IGT, with a value similar to GT group. GT extract also normalized the activities of antioxidant enzymes superoxide dismutase and catalase in the IGT group, when compared to MI...

Animals , Male , Rats , Camellia sinensis , Myocardial Infarction/chemically induced , Ventricular Remodeling , Rats, Wistar
Botucatu; s.n; 2013. 77 p. ilus, tab.
Thesis in Portuguese | LILACS | ID: lil-751561


O objetivo do nosso estudo foi de avaliar a influência do período de início da atividade física sobre a remodelação após o infarto em ratos, por meio de análise de variáveis morfológicas, funcionais, bioquímicas, celulares e intersticiais cardíacas. Foram utilizados ratos wistar, machos, entre 200 – 250g foram submetidos ao infarto experimental. Após 48hs do procedimento, os animais sobreviventes foram alocados em três grupos aleatoriamente: grupo S (n=24): grupo de animais infartados; grupo P (n=24): grupo de animais infartados exercitados precocemente; grupo T(n=24): grupos de animais infartados exercitados tardiamente. Após 3 meses de acompanhamento foi realizado estudo morfológico e funcional pelos seguintes métodos: coração isolado, ecocardiograma, morfometria e histologia. O estudo bioquímico foi realizado pela área de miócitos, tamanho do infarto e porcentagem de colágeno do tecido cardíaco, por espectrofotometria foram avaliados estresse oxidativo e metabolismo energético. A análise estatística foi realizada pelo teste de ANOVA de uma via, O nível de significância adotado foi de 5%. Os resultados morfológicos avaliados pelo ecocardiograma mostram que os animais do grupo exercitado tardiamente apresentaram menor espessura da parede septal que o grupo P (S=1,69±0,28; P=1,81±0,34; T=1,46±0,22; p=0,041) e menores áreas diastólicas (S=105±12; P=96±23; T=87±11; p=0,010) e sistólicas (S=76±8; P=69±8; T=62±9; p=0,012) que o grupo S...

The aim of our study was to evaluate the influence of the period of early physical activity on remodeling after infarction in rats by analysis of morphological, functional, biochemical, cellular and interstitial heart. Wistar rats were used, males, between 200 - 250g were subjected to experimental infarction. After 48 hours of the procedure, the surviving animals were randomly allocated into three groups: group S (n = 24): group of infarcted animals, group P (n = 24): group of infarcted animals exercised early; Group T (n = 24) : groups of infarcted animals exercised later. After 3 months of followup was conducted morphological and functional study of the following methods: isolated heart, echocardiography, histology and morphometry. Biochemical analysis was performed by the area of myocytes, infarct size and percentage of collagen in the cardiac tissue were assessed by spectrophotometry oxidative stress and energy metabolism. Statistical analysis was performed by ANOVA one-way, the significance level was 5%. Morphological assessed by echocardiogram showed that the animals in the late exercised had lower septal wall thickness that the group P (S = 1.69 ± 0.28, P = 1.81 ± 0.34, T = 1 , 46 ± 0.22, p = 0.041) and lower diastolic areas (S = 105 ± 12, P = 96 ± 23, T = 87 ± 11, p = 0.010) and systolic (S = 76 ± 8, P = 69 ± 8, T = 62 ± 9, p = 0.012) than the group S...

Animals , Male , Rats , Exercise , Myocardial Infarction/chemically induced , Ventricular Remodeling
Botucatu; s.n; 2013. 85 p. ilus, tab.
Thesis in Portuguese | LILACS | ID: lil-756926


O processo de remodelação cardíaca após o infarto do miocárdio está associado a pior prognóstico. Na fase aguda, a remodelação favorece a formação do aneurisma e predispõe o coração infartado à ruptura ventricular. Cronicamente, está associada com maior prevalência de arritmias malignas e disfunção ventricular, pois a região infartada sofre alterações genéticas, estruturais e bioquímicas que vão resultar em deterioração da capacidade funcional do coração e morte. Portanto, estratégias que atenuam a remodelação resultam em melhora do prognóstico pós-infarto. Evidências recentes sugerem que alterações dos níveis de vitamina D podem resultar em importantes ações cardiovasculares. Adicionalmente, modelos experimentais sugerem que ela poderia modular o processo de remodelação cardíaca. Porém, os efeitos da suplementação de vitamina D sobre o coração após o infarto não são conhecidos. No nosso protocolo, avaliamos os efeitos da suplementação de vitamina D nas alterações morfológicas e funcionais cardíacas após o infarto agudo do miocárdio em ratos, por meio do estudo de alguns dos principais mecanismos envolvidos no processo de remodelação cardíaca: hipertrofia e alterações da geometria ventricular, alterações funcionais, quantidade de colágeno, estresse oxidativo, metabolismo energético, inflamação, apoptose e alterações na distribuição das cadeias pesadas da miosina...

The process of cardiac remodeling after myocardial infarction is associated with poor outcome. In the acute phase, remodeling promotes the formation of the aneurysm and predisposes to ventricular rupture. Chronically, it is associated with higher prevalence of malignant arrhythmias and ventricular dysfunction, because the non infarcted region undergoes genetic, structural and biochemical changes which will result in impairment of functional capacity of the heart and death. Therefore, strategies to attenuate remodeling result in improved prognosis after myocardial infarction. Recent evidence suggests that changes in the levels of vitamin D can result in important cardiovascular actions. Additionally, experimental models suggest that it could modulate cardiac remodeling process. However, the effects of vitamin D supplementation on heart after infarction are not known. In our study, we assessed the effects of vitamin D supplementation on cardiac morphological and functional changes after acute myocardial infarction in rats by studying some of the key mechanisms involved in heart remodeling: hypertrophy and changes in ventricular geometry, functional changes, collagen amount, oxidative stress, energy metabolism, inflammation, apoptosis and changes in the distribution of myosin heavy chains. In our results, we found that infarcted animals that received vitamin D supplementation had higher left ventricle systolic and diastolic diameters increased systolic and diastolic areas associated with decreased fractional area change, ejection fraction and posterior wall shortening velocity, decreased systolic blood pressure, increased apoptosis by increasing the expression of proteins caspase 3 and decreased bcl-2, decreased activity of the enzyme phosphofructokinase. There was no interaction between infarct and vitamin D for myosin heavy chains, metalloproteinase activity, oxidative stress, ICAM-1, IL-10 and TIMP...

Animals , Male , Rats , Myocardial Infarction/chemically induced , Ventricular Remodeling , Vitamin D , Rats, Wistar
Botucatu; s.n; 2012. 79 p. ilus, tab.
Thesis in Portuguese | LILACS | ID: lil-750907


O objetivo do nosso estudo foi de avaliar a influência da administração de taurina sobre a remodelação após o infarto em ratos, por meio de análise de sobrevida e de variáveis morfológicas, funcionais, bioquímicas, celulares e intersticiais cardíacas. Foram utilizados ratos wistar, machos, entre 200 – 250g foram submetidos ao infarto experimental. Após 48hs do procedimento, os animais sobreviventes foram alocados em dois grupos aleatoriamente: grupo IAM (n=31), o qual recebeu água potável e grupo IAM-T (n=30), que recebeu 3% de taurina diluída na água. O grupo controle (n=10) foi composto por animais não infartados e recebeu água potável. Após 3 meses de acompanhamento foi realizado estudo morfológico e funcional pelos seguintes métodos: coração isolado, ecocardiograma, morfometria e histologia. O estudo bioquímico foi realizado por HPLC (para determinar as concentrações e taurina no plasma e no tecido cardíaco). A imunohistoquímica foi utilizada para avaliar a conexina 43 e apoptose. Por meio da zimografia avaliou-se as metaloproteases, por espectrofotometria foram avaliados estresse oxidativo e metabolismo energético e por western blot avaliou-se a resposta antioxidante. A análise estatística foi realizada pelo teste de ANOVA de uma via, t de Student, curva de Kaplan Méier e long – rank. O nível de significância adotado foi de 5%. A concentração de taurina plasmática (C = 49 (38 – 54,2) (μmol/L); IAM = 74,6 (58,7 – 83) (μmol/L); IAM-T = 363 (157 - 477,4) (μmol/L); p = 0,004) e no tecido cardíaco (C = 0,100 ± 0,04 (μmol/g); IAM = 0,175 ± 0,07 (μmol/g); IAM-T = 0,419± 0,187 (μmol/g); p = 0,022) foi maior no grupo IAM-T quando comparado com controle e IAM...

The aim of our study was to evaluate the influence of taurine administration on cardiac remodeling after myocardial infarction in rats by survival analysis and morphological, functional, biochemical, cellular and interstitial evalluation. Methods: Wistar male rats, weighting 200 - 250g were subjected to experimental myocardial infarction. 48 hours after the procedure, the surviving animals were randomly allocated into two groups: IAM group (n = 31), who received drinking tap water and T-IAM group (n = 30), who received 3% of taurine diluted in tap water. The control group (n = 10) was composed of non infarcted animals, who received drinking tap water. After 3 months of follow-up, morphological and functional study was conducted by the following. Isolated heart, echocardiography, histology and morphometry. Biochemical analysis was performed by HPLC (to determine the concentrations of taurine in plasma and heart tissue). Immunohistochemistry was used to evaluate connexin 43 and apoptosis. Metalloproteases was evaluated by zymography, oxidative stress and energy metabolism were evaluated by spectrophotometry and the antioxidant response, by western blot. Statistical analysis was performed by oneway ANOVA, Student t test, Kaplan Meier and long – rank tests. The level of significance was set at 5%...

Animals , Male , Rats , Apoptosis , Energy Metabolism , Myocardial Infarction/chemically induced , Oxidative Stress , Ventricular Remodeling , Taurine/physiology , Rats, Wistar
Rev. bras. cir. cardiovasc ; 26(3): 469-476, jul.-set. 2011.
Article in Portuguese | LILACS | ID: lil-624531


OBJETIVO: Avaliar e validar, em nosso meio, o modelo de infarto do miocárdio induzido por isoproterenol em ratos por meio de análises de parâmetros hematológicos, bioquímicos, de marcadores do estresse oxidativo e histopatológicos. MÉTODOS: Trinta ratos jovens, machos, da linhagem Wistar (145 a 230 g), foram alocados aleatoriamente em dois grupos: grupo Simulado, submetido à falsa indução de infarto do miocárdio, e grupo Infarto, submetido à indução do infarto do miocárdio com isoproterenol. As aplicações, para indução do infarto, foram realizadas durante dois dias consecutivos, com intervalo de 24 horas entre elas. Após 24 horas da última aplicação, os ratos de ambos os grupos foram anestesiados e sacrificados para realização de coleta de sangue para hemograma e análise bioquímica (TGO, TGP, troponina I, ureia e creatinina) e coleta de fragmento do miocárdio para avaliação de marcadores do estresse oxidativo (atividade da catalase e concentração de glutationa) e exame histopatológico. RESULTADOS: Não houve mortalidade no grupo Simulado, enquanto a mortalidade no grupo Infarto foi de 25%. A indução do infarto do miocárdio com isoproterenol causou elevação das contagens de leucócitos e neutrófilos, dos níveis de TGO, troponina I e ureia, reduziu a atividade da catalase e os níveis teciduais de glutationa e causou alterações histopatológicas. Não acarretou alterações nas concentrações de hemoglobina, TGP e creatinina. CONCLUSÕES: O modelo de infarto do miocárdio induzido por isoproterenol em ratos foi adequadamente reproduzido em nosso laboratório, acarretando alterações em parâmetros hematológicos, bioquímicos, de marcadores de estresse oxidativo e histopatológicos.

OBJECTIVE: To evaluate and validate, in our laboratory, the essay of myocardial infarction induced by isoproterenol in rats by means of analysis of hematological, biochemical, oxidative stress markers and histopathological parameters. METHODS: Thirty young, male, Wistar rats (145 to 230 g) were randomly allocated in two groups: Sham group, which underwent a virtual myocardial infarction induction, and the Infarction group, which underwent a myocardial infarction induction with isoproterenol. The administrations for the infarction induction were performed during two consecutive days and a 24-hour interval between them. Twenty-four hours after the last administration, rats from both groups were anesthetized and sacrificed for blood sample collection to evaluate complete blood count (CBC) and biochemical parameters (SGOT, SGPT, troponin I, urea and creatinin), obtain myocardial fragments for oxidative stress markers analyses (catalase activity and glutathione concentrations) as well as histopathological examinations. RESULTS: There were no death cases in the Sham group, while the mortality rate in the Infarction group was 25%. Myocardial infarction induction with isoproterenol raised leukocytes and neutrophils counts, SGOT, troponin I and urea concentrations, reduced catalase enzyme activity and glutathione concentrations in the myocardium and let to histopathological concentrations as well. It did not exert alterations in terms of hemoglobin, SGPT and creatinin concentrations. CONCLUSIONS: The isoproterenol-induced myocardial infarction essay in rats was adequately reproduced in our laboratory, causing alterations in hematological, biochemical, oxidative stress markers and histopathological parameters.

Animals , Male , Rats , Aspartate Aminotransferases/blood , Cardiotonic Agents/adverse effects , Catalase/blood , Glutathione/blood , Isoproterenol/adverse effects , Myocardial Infarction/chemically induced , Troponin I/blood , Biomarkers/blood , Disease Models, Animal , Myocardial Infarction/blood , Myocardial Infarction/pathology , Oxidative Stress/physiology , Random Allocation , Rats, Wistar
Indian J Biochem Biophys ; 2011 Feb; 48(1): 22-28
Article in English | IMSEAR | ID: sea-135296


The cardioprotective potential of Inula racemosa root hydroalcoholic extract against isoproterenol-induced myocardial infarction was investigated in rats. The rats treated with isoproterenol (85 mg/kg, s.c.) exhibited myocardial infarction, as evidenced by significant (P<0.05) decrease in mean arterial pressure, heart rate, contractility, relaxation along with increased left ventricular end diastolic pressure, as well as decreased endogenous myocardial enzymatic and non-enzymatic antioxidants. Isoproterenol also significantly (P<0.05) induced lipid peroxidation and increased leakage of myocyte injury marker enzymes. Pretreatment with I. racemosa extract (50, 100 or 200 mg/kg per day, p.o.) for 21 consecutive days, followed by isoproterenol injections on days 19th and 20th significantly (P<0.05) improved cardiac function by increasing the heart rate, mean arterial pressure, contractility and relaxation along with decreasing left ventricular end diastolic pressure. Pretreatment with I. racemosa also significantly (P<0.05) restored the reduced form of glutathione and endogenous antioxidant enzymes superoxide dismutase, catalase, glutathione peroxidase from the heart, which were depleted after isoproterenol administration. In addition to restoration of antioxidants, I. racemosa significantly (P<0.05) inhibited lipid peroxidation and prevented the leakage of myocytes specific marker enzymes creatine phosphokinase-MB and lactate dehydrogenase from the heart. Thus, it is concluded that I. racemosa protects heart from isoproterenol-induced myocardial injury by reducing oxidative stress and modulating hemodynamic and ventricular functions of the heart. Present study findings demonstrate the cardioprotective effect of I. racemosa and support the pharmacological relevance of its use and cardioprotection mechanism in ischemic heart disease as well as substantiate its traditional claim

Animals , Catalase/drug effects , Catalase/metabolism , Creatine Kinase, MB Form/drug effects , Creatine Kinase, MB Form/metabolism , Glutathione/drug effects , Glutathione/metabolism , Glutathione Peroxidase/drug effects , Glutathione Peroxidase/metabolism , Heart Rate/drug effects , Hemodynamics/drug effects , Inula , Isoproterenol , L-Lactate Dehydrogenase/drug effects , L-Lactate Dehydrogenase/metabolism , Lipid Peroxidation/drug effects , Male , Myocardial Infarction/chemically induced , Myocardial Infarction/drug therapy , Oxidative Stress/drug effects , Phytotherapy/methods , Plant Extracts/pharmacology , Plant Roots/metabolism , Rats , Rats, Wistar , Superoxide Dismutase/drug effects , Superoxide Dismutase/metabolism , Ventricular Function, Left/drug effects
J. bras. patol. med. lab ; 45(5): 385-388, out. 2009. ilus
Article in Portuguese | LILACS | ID: lil-536889


Com os aumentos da difusão e da facilidade de acesso à cocaína, registra-se aumento da morbidade e da mortalidade associadas ao seu uso. O seu consumo tem sido associado a doenças cardiovasculares (DCVs), entre elas isquemia e infarto do miocárdio. Desde o primeiro relato de associação entre o consumo de cocaína, isquemia miocárdica e infarto, os efeitos cardiovasculares da cocaína vêm sendo amplamente estudados, a fim de se estabelecerem seus mecanismos fisiopatológicos, alterações estruturais, diagnóstico, repercussões hemodinâmicas e prognóstico. O objetivo deste estudo foi relatar um caso de múltiplos infartos do miocárdio induzido pelo uso de cocaína com estudo necroscópico.

The increased distribution and access to cocaine, lead to an increase of morbidity and mortality associated with its use. Cocaine use has been associated with cardiovascular diseases, among them ischemia and myocardial infarction. Since the first report of association between the use of cocaine, myocardial ischemia and infarction in 1982, the cardiovascular effects of cocaine have been extensively studied in order to establish its pathophysiological mechanism, structural changes, methods of diagnosis, prognosis and homodynamic effects. This study reports a case of multiple myocardial infarction induced by the use of cocaine with necroscopic study.

Humans , Male , Adult , Cocaine/adverse effects , Myocardial Infarction/diagnosis , Myocardial Infarction/chemically induced , Cocaine-Related Disorders/complications , Autopsy , Myocardial Infarction/mortality